Tia Stock
Enable every person to achieve their own definition of optimal health through science-backed information, access to high-quality care, and community.
Sign up today and learn more about Tia Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tia Stock
At Tia, we believe that the healthcare system was not built with women in mind. Today, considering that women control 80% of healthcare dollars in the U.S., Tia is seizing the opportunity to build a new, distinctly female model of care digitally and physically.Â
Investors
Torch Capital
Define Ventures
Threshold
Zymergen, BetterUp, Talkdesk, Remitly, Divvy Homes, Prosper Marketplace, CircleCI, Viz, d.light design, Mythic
Homebrew
Chime, Carbon Health, Gusto, Plaid, Shield AI, Bowery Farming, Mercury, Tia, Shyp, Chain
Funding History
January 2019 | $2.5M |
---|---|
March 2019 | $6.0M |
May 2020 | $24.3M |
September 2021 | $100M |
Management
Co-Founder & COO
Felicity Yost
Co-Founder & CEO
Carolyn Witte
Head of Learning and Development
Kristin Ryan
VP of Operations
Ariella Willoughby
Head of Patient Tech
Ari Weiss
Head of Go-to-Market Strategy
Faye Leong
Head of Business Operations & Strategy
Julia Marley-Rappoport
Head of Growth Marketing
Jennifer Lewis
Head of Research
Ava Mainieri
Head of Virtual Care Product
Laura Ardilla
VP of Virtual Care and Clinical Operations
Jessica Horwitz
Head Of Design
Allison Ball
Advisor
Dan Zigmond
VP of Payer Strategy and Revenue Cycle
Tom Barnes
Senior VP of Medical Affairs
Kathleen Jordan
Head of Engineering
Eric Dargelies
Press
techdirt - Feb, 3 2024
Daily Deal: The Complete 2024 CompTIA Certification Training Super Bundle by IDUNOVApulse2 - Jan, 30 2024
Thentia: Regulatory Technology Company Raises $38 Milliontradingview - Jan, 14 2024
Bitcoin price crumbles after spot ETF approval, but ICP, TIA, MNT, SEI and altcoins reboundfiercetelecom - Nov, 19 2023
Fierce Telecom teams with TIA to solve broadband workforce problempharmiweb - Oct, 20 2023
Incontinentia Pigmenti Treatment Market is Projected to Reach at a CAGR of 5.20% By 2029